INTERNATIONAL AIDS VACCINE INITIATIVE INC.
Federal contract awards won by INTERNATIONAL AIDS VACCINE INITIATIVE INC. (UEI ZEJBC8JQM3P5), 2018–2023 — public record from USAspending.
Showing awards of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
14
awards
$533,591,556
total value
2
agencies
Agencies buying from INTERNATIONAL AIDS VACCINE INITIATIVE INC.
What INTERNATIONAL AIDS VACCINE INITIATIVE INC. sells
541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) (7)541712 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) (4)541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) (3)
Awards
CONTRACT HHSN272201800010I INTERNATIONAL AIDS VACCINE INITIATIVE MANUFACTURE OF INFLUENZA VIRUS HUMAN CHALLENGE MATERIAL FOR PHASE I AND II CLINICAL TESTING
Department of Health and Human Services · $3,625,389 · Sep 26, 2023
PRECLINICAL SERVICES FOR BIOPHARMACEUTICAL PRODUCT DEVELOPMENT: BASE IDIQ
Department of Health and Human Services · $30,000,000 · Sep 8, 2023
PRECLINICAL AND TRANSLATIONAL VACCINE DEVELOPMENT FOR HIV AND OTHER CANDIDATE AGENTS
Department of Health and Human Services · $3,974,723 · Dec 1, 2021
THE CONTRACTOR SHALL PROVIDE NIAID WITH A BROAD AND FLEXIBLE RANGE OF CAPABILITIES THAT ARE REQUIRED FOR PRECLINICAL AND TRANSLATIONAL DEVELOPMENT SUPPORT FOR PROMISING VACCINES AND RELATED PRODUCTS FOR HIV AND OTHER CANDIDATE AGENTS. THE CONTRACTOR
Department of Health and Human Services · $364,553,934 · Dec 1, 2021
THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF MONOVALENT VACCINES FOR PREVENTION OF MARBURG VIRUS (MARV) AND SUDAN EBOLAVIRUS (SUDV) DISEASE. THESE VACCINES ARE BASED ON RECOMBINANT EXPRESSION OF FILOVIRUS GLYCOPROTEINS IN
Department of Health and Human Services · $94,036,149 · Sep 30, 2021
THIS TASK ORDER IS TO DEVELOP AN OPTIMIZED PHASE 1 CGMP MANUFACTURING PROCESS FOR LIPID NANOPARTICLE (LNP) FABRICATION THAT ENABLE COVALENT COUPLING OF AN HIV-1 ENV TRIMER TO THE SURFACE OF THE LNP. A NON-GMP PROCESS RUN OF DRUG PRODUCT SHALL BE PERF
Department of Health and Human Services · $1,615,732 · Sep 15, 2021
HHSN272201800010I IAVI STORAGE OF GMP AND NON-GMP MATERIALS FOR NIAID BASE AWARD, CAN 8470038 FOR $435,313.50 CAN 8040917 FOR $435,313.50 TOTAL $870,627
Department of Health and Human Services · $588,135 · Sep 14, 2021
COORDINATION AND TECHNICAL SUPPORT
Department of Health and Human Services · $358,683 · Jul 15, 2021
ACCELERATED DEVELOPMENT OF A SARS-COV-2 VACCINE BASED ON THE LIVE VSVAG CHIMERIC VIRUS PLATFORM
Department of Defense · $26,261,466 · Oct 5, 2020
1800010I IAVI BASE AWARD $810,077 FY20 CELL LINE OPTIMIZATION AND PRE-MASTER BANK GENERATION FOR SB 301, A VACCINE FOR HEPATITIS B VIRUS (HBV) TOVM20V24VB 2 IID CAN 8470036
Department of Health and Human Services · $1,098,404 · Sep 22, 2020
NANOPARTICLE-BASED DEVELOPMENT FOR HIV-1 BIOMOLECULE DELIVERY
Department of Health and Human Services · $713,686 · Aug 15, 2019
PROCESS AND ASSAY DEVELOPMENT FOR CGMP PRODUCTION AND CHARACTERIZATION OF A VSV CANDIDATE
Department of Health and Human Services · $949,225 · Aug 8, 2019
1800010I INTERNATIONAL AIDS VACCINE INITIATIVE TO V3 OBRA--2 BASE TASK ORDER FUNDING BIOD CAN 8470038 $642,953
Department of Health and Human Services · $1,753,724 · Feb 28, 2019
1800010I INTERNATIONAL AIDS VACCINE INITIATIVE MANUFACTURE OF HUMAN FLU CHALLENGE MATERIAL
Department of Health and Human Services · $4,062,306 · Aug 28, 2018
Researching this competitor? BidCatch doesn't just show you what they won — it sends you the open bids in your trade every morning, before they're awarded. Free for 14 days, then $49.99/month.
Search open bids